Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × spartalizumab × 1 year × Clear all

Sponsor

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 7 Pancreatic Neoplasms 6 Colorectal Neoplasms 6 Stomach Neoplasms 5 Carcinoma, Renal Cell 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Rectal Neoplasms 4 Nasopharyngeal Carcinoma 4 Neoplasm Metastasis 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Solid Tumors 2 Solid Tumor 2 Skin Neoplasms 2 Ovarian Neoplasms 2 Neoplasms 2 Myelodysplastic Syndromes 2 Lung Neoplasms 2 Locally Advanced Rectal Cancer 2 Leukemia, Myelomonocytic, Chronic 2 Glioblastoma 2 Esophageal Squamous Cell Carcinoma 2 Breast Neoplasms 2 Advanced Solid Tumors 2 von Hippel-Lindau Disease 1 Thyroid cancer, follicular 1 Thyroid cancer, Hurthle cell 1

Interventions

Cyclophosphamide 5 Radiotherapy 3 Automobiles 3 fludarabine 2 Vincristine 2 Temozolomide 2 Eflornithine 2 Cisplatin 2 omburtamab I-131 1 ibrutinib 1 gallium Ga 68 dotatate 1 belzutifan 1 Zoledronic Acid 1 Standard of Care 1 Radiotherapy, Image-Guided 1 Pemetrexed 1 ONC206 1 Nivolumab 1 Maintenance Chemotherapy 1 Lomustine 1 Infusions, Intravenous 1 Induction Chemotherapy 1 HhAntag691 1 Gemcitabine 1 Exercise 1 Etoposide 1 Drug Therapy 1 Diploidy 1 Craniospinal Irradiation 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡